Designating Familial Adenomatous Polyposis Awareness Week
May 7, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
Where This Stands
Currently Unknown. The next step in the legislative lifecycle is Introduced.
Procedural history
1 action- May 7, 2026SenateIntroducedIntroduced. Referred to Com. on RLS.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →The Frame
The bill establishes a state-recognized awareness week, which serves to promote public education and medical screening for a hereditary condition that significantly increases the risk of colorectal cancer.
Potentially affected actors named in the source documents. Mention is not a position.
Patients with Familial Adenomatous Polyposis
The bill provides state-level recognition of their medical condition through a designated awareness week.
Last recorded activity May 7, 2026.
Introduced.
Summary
Key Facts
- The bill was introduced on May 7, 2026.
- The bill was referred to the Committee on Rules.
- The bill underwent author's amendments on May 13, 2026.
- The bill was read for a second time on May 13, 2026.
- The bill was ordered to a third reading on May 20, 2026.
Frequently Asked Questions
What is Familial Adenomatous Polyposis?
What is the current status of this bill?
Why It Matters
The bill establishes a state-recognized awareness week, which serves to promote public education and medical screening for a hereditary condition that significantly increases the risk of colorectal cancer.
News Coverage
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Rapid Legislative Movement
The bill moved from introduction to a third reading within 13 days, indicating a high priority for the legislative calendar.
Connected Entities
Sources
openstates.org
Analysis Score
0–100- Significance15How much this matters to a regular citizen
- Controversy0Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools